Med2House Services Private Limited - Due diligence report

A 360° intelligence report on Med2House: trust score, financial health, credit view, compliance, directors, growth and distress signals - ge…

2016-03-16 Trivandrum, Kerala Strike Off Unlisted Active Non-Compliant
Share
MS Med2House Services Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Med2House — 360° Intelligence Report

Generated from MCA filings & public records
46/100
Trust Score
Caution Indicated

Med2House is assessed as Caution Indicated with a Trust Score of 46/100. Med2House is a private limited indian non-government company incorporated in 2016, operating in the Trading sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and moderate financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Med2House Services Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
46/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
10/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 1 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 38%).

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 10/100 Caution Indicated
  • Company status is "Strike Off" - not Active.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2017 - filings overdue.
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
NITHIN PAUL CHERIAN 01234567 Director 01/04/2018 6 yrs Approved
ANILKUMAR GANGADHARANNAIR 01234567 Director 01/04/2018 6 yrs Approved
KIZHAKKEVEETIL ABDUL UBAIDULLA 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • ANILKUMAR GANGADHARANNAIR has DIN status "Disqualified by RoC u/s 164(2)".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 6 transfer(s)

Promoters hold a majority stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 55
Growth signals & trust indicators
Operating for 10+ years.
Distress signals & risk flags
Statutory filings appear overdue.
Adverse company status: Strike Off.
Compliance score is weak (10/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence34/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment42/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view29/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
20 Dec 2017
Director ceased
ANILKUMAR GANGADHARANNAIR
07 Dec 2017
Director appointed
NITHIN PAUL CHERIAN (Director)
30 Sep 2017
Last AGM held
Annual general meeting
31 Mar 2017
Share transfer (FY 2017)
6315.00000000 shares to Paul Cherian
Share transfer (FY 2017)
7696.00000000 shares to Kumar
Share transfer (FY 2017)
1886.00000000 shares to Kumar
Share transfer (FY 2017)
435.00000000 shares to Paul Cherian
Share transfer (FY 2017)
2027.00000000 shares to Kizhakkeveettil
Share transfer (FY 2017)
1793.00000000 shares to Kesavamenon
Latest balance sheet
Filed with ROC
29 Mar 2017
Securities allotted
689 Equity Shares - 1.10 Lakh raised
28 Jan 2017
Securities allotted
1350 Equity Shares - 2.00 Lakh raised
22 Nov 2016
Director ceased
BALAGOPAL KESAVAMENON
16 Mar 2016
Incorporated
Registered with Roc Ernakulam
Director appointed
ANILKUMAR GANGADHARANNAIR (Director)
10

Key Observations

Auto-generated from the data above
3 active director(s) / partner(s); review board churn before relying on management continuity.
Promoters hold a majority stake as per the FY 2017 annual return.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Maganlal Impex Private Limited U17120MH1980PTC122204 Mumbai, Maharashtra, India
Samriddhi Enterprises Private Limited U74900TG2016PTC103028 Hyderabad, Telangana, India
Haritwal Securities Private Limited U67120WB2007PTC115837 Kolkata, West Bengal, India
Overtop Construction Private Limited U45400WB2012PTC183004 Kolkata, West Bengal, India
Imperial Furniture Company Private Limited U74899DL1995PTC066467 New Delhi, Delhi, India
Happy Online Shopping India Private Limited U74999TN2012PTC085464 Madurai, Tamil Nadu, India
Income Marketing Private Limited U52599MH2007PTC167906 Mumbai, Maharashtra, India
Escan Export And Import Private Limited U52100DL2011PTC225576 New Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Med2House before audits and certifications: compliance score 10/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Med2House: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Med2House - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 46/100, distress signals and MSME payment-delay disclosures - know whether Med2House pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Med2House - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Med2House an active company?

Med2House has MCA status “Strike Off” with a compliance score of 10/100 (Caution Indicated).

Is Med2House financially healthy?

Med2House has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Med2House?

Its overall Trust Score is 46/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Med2House?

Promoters hold a majority stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Med2House have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Med2House up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 10/100 (Caution Indicated).

Is it risky to lend to Med2House?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.